Impact of Recombinant Human Growth Hormone on HIV Persistence

Clinical trial NCT03091374 · COMPLETED

Trial details

NCT number: NCT03091374
Sponsor: McGill University Health Centre/Research Institute of the McGill University Health Centre
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Human Immunodeficiency Virus Growth Hormone Treatment

Start date: 2016-12-01
Primary completion: 2021-03-01
Enrollment: 22

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.